21 May 2019. Source: Healthcare IT

The country’s regulations on gene technology are being updated to clarify the regulatory status of new genome editing techniques and provide additional benefits to cancer patients and the medical research community. The amendments will make it quicker and easier for medical researchers to do early proof of concept work and progress to clinical trials with patients, including work to identify genes involved in diseases. The regulation amendments had been made on behalf of the Legislative and Governance Forum on Gene Technology to make the legal position of genome editing clearer.